Chemoinformaics analysis of 7-Methoxy-6-methyl-9H-carbazol-3-ol
| Molecular Weight | 227.263 | nRot | 1 |
| Heavy Atom Molecular Weight | 214.159 | nRig | 15 |
| Exact Molecular Weight | 227.095 | nRing | 3 |
| Solubility: LogS | -4.914 | nHRing | 1 |
| Solubility: LogP | 6.757 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 15 |
| nHA | 2 | APOL | 34.7523 |
| nHD | 2 | BPOL | 15.3477 |
| QED | 0.07 |
| Synth | 4.875 |
| Natural Product Likeliness | 1.147 |
| NR-PPAR-gamma | 0.972 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.08 |
| Pgp-sub | 0.186 |
| HIA | 0.236 |
| CACO-2 | -5.328 |
| MDCK | 0.0000144 |
| BBB | 0.007 |
| PPB | 0.960577 |
| VDSS | 1.009 |
| FU | 0.0290972 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.681 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.04 |
| CYP2c9-sub | 0.878 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.288 |
| CYP3a4-inh | 0.07 |
| CYP3a4-sub | 0.027 |
| CL | 10.482 |
| T12 | 0.074 |
| hERG | 0.022 |
| Ames | 0.051 |
| ROA | 0.368 |
| SkinSen | 0.964 |
| Carcinogencity | 0.021 |
| EI | 0.008 |
| Respiratory | 0.167 |
| NR-Aromatase | 0.934 |
| Antiviral | Yes |
| Prediction | 0.714415 |